- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04539704
Assessing Impacts of Static Magnetic Fields on Peripheral Pulses and Skin Blood Flow
April 19, 2023 updated by: Harvey N. Mayrovitz, PhD, Nova Southeastern University
The purpose of this research study is to investigate and determine the effects of static magnetic fields produced by a small magnet on peripheral pulses and skin blood flow.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
A specific neodymium magnet and sham device will be placed on certain sites near the ulnar and medial arteries and the effect of such placement on peripheral pulses assessed via PPG on fingers and on skin blood flow via laser Doppler perfusion determined.
These assessments will be made while healthy subjects are lying supine on a padded examination table over a time interval of about 45-60 minutes.
In addition to the impact that either the magnet or the sham devices have, the pulse and skin blood flow patterns and features will be analyzed from the point of view of sequential variability with and eye toward developing related parameters to potentially improve such variability.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Harvey Mayrovitz
- Phone Number: 9547429921
- Email: mayrovit@nova.edu
Study Locations
-
-
Florida
-
Davie, Florida, United States, 33328
- Recruiting
- Nova Southeastern University
-
Contact:
- Harvey Mayrovitz
- Phone Number: 954-205-7199
- Email: mayrovit@nova.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age between 18-35 years
- No known neurological deficit
- No known cardiovascular condition
Exclusion Criteria:
- Unable or unwilling to lie reasonably still for about 55 minutes
- Known to have diabetes of any type
- Having any metallic or wire implant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Healthy Adults-magnet
Healthy adults with magnet and/or sham
|
In same subject some areas will have magnet and others will have sham
|
Sham Comparator: Healthy Adults-sham
Healthy adults with magnet and/or sham
|
In same subject some areas will have magnet and others will have sham
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of magnet on skin blood flow
Time Frame: one hour
|
skin blood flow
|
one hour
|
Effect of magnet on arterial pulses
Time Frame: one hour
|
Pulse values and paterns
|
one hour
|
Characterization of temporal pattern of pulse changes and their amelioration
Time Frame: one hour
|
variability with and without normalization
|
one hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Anticipated)
December 31, 2024
Study Completion (Anticipated)
December 31, 2024
Study Registration Dates
First Submitted
August 31, 2020
First Submitted That Met QC Criteria
August 31, 2020
First Posted (Actual)
September 7, 2020
Study Record Updates
Last Update Posted (Actual)
April 20, 2023
Last Update Submitted That Met QC Criteria
April 19, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-598-NSU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaNot yet recruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Marissa JarosinskiRecruitingPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
-
Jena University HospitalAngioDroid s.r.l., Bologna (Italy)CompletedPeripheral Arterial Occlusive DiseaseGermany
-
Seoul National University HospitalAstellas Pharma Korea, Inc.CompletedPeripheral Arterial Occlusive DiseaseKorea, Republic of
-
Heidelberg UniversityTerminatedPeripheral Arterial Occlusive DiseaseGermany
-
Johann Wolfgang Goethe University HospitalSuspendedPeripheral Arterial Occlusive DiseaseGermany
Clinical Trials on magnet and sham
-
University Hospital of North NorwayUiT The Arctic University of NorwayRecruitingDepression | Executive DysfunctionNorway
-
Children's Mercy Hospital Kansas CityCornell University; The Methodist Hospital Research InstituteWithdrawnTourette SyndromeUnited States
-
National University of Natural MedicineOregon Health and Science University; National Center for Complementary and...UnknownCarpal Tunnel SyndromeUnited States
-
George Washington UniversityCompletedGastritis | Abdominal Pain | Gastric Cancer | Gastric UlcerUnited States
-
Nova Southeastern UniversityCompleted
-
Pulse TherapeuticsSuspendedCerebrovascular Disorders | Neurologic Disorder | Infarction, Middle Cerebral Artery | Stroke, Ischemic | Stroke, Acute | Intracranial Embolism and Thrombosis | Strokes ThromboticUnited Kingdom
-
Northwestern UniversityCompletedNausea | Vomiting | Pregnancy Related | Cesarean DeliveryUnited States
-
University of ManitobaCanadian Institutes of Health Research (CIHR); CancerCare ManitobaCompleted
-
Heart and Diabetes Center North-Rhine WestfaliaRecruitingTricuspid Valve InsufficiencyGermany
-
University Hospital, Basel, SwitzerlandClinical Trial Unit, University Hospital Basel, SwitzerlandCompleted